Fred Aslan

ARTV

Fred Aslan serves as director, officer: Chief Executive Officer at Artiva Biotherapeutics, Inc. (ARTV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$608.3K

Net Position

Net Seller

$608.3K

Companies Traded

ARTV

Active Period

May 2025 – May 2026

6 total trades

Most Recent

Sell ARTV

May 19, 2026 · $244.3K

Fred Aslan's Insider Trading at Artiva Biotherapeutics, Inc. (ARTV)

Buys

0 · $0.00

Sells

6 · $608.3K

Total Shares Bought

Total Shares Sold

117,569

ARTV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 19, 2026	Sell	27,116	$9.01	$244.3K	1,535,082
Feb 15, 2026	Sell	14,600	$4.00	$58.4K	0
Dec 15, 2025	Sell	3,187	$6.00	$19.1K	0
Nov 15, 2025	Sell	12,722	$3.31	$42.1K	0
Oct 17, 2025	Sell	25,500	$6.00	$153.0K	0
May 15, 2025	Sell	34,444	$2.65	$91.4K	0